Industrifonden - Community Facebook

Karim Engelmark Cassimjee - Stockholm, Sverige - LinkedIn

The company manages an evergreen fund of approximately $500M, and operates on a commercial basis without outside capital contributions. EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden’s Industrifonden EnginZyme is a biotechnology company that specializes in biocatalysis. EnginZyme erweitert Serie-A-Finanzierung auf 11 Mio. Euro, um seine zellfreie Chemieproduktionsplattform voranzubringen – Finanzierungsrunde geführt vom schwedischen Investor Industrifonden EnginZyme is seeking a Chief Financial Officer to lead the company's financial operations and funding strategy. EnginZyme is a Swedish startup founded in 2014 that has developed a platform for sustainably producing both the current building blocks of the world — the billion tonnes of plastics, nylons, rubbers, and all the other things that we touch on a day-to-day basis — as well as The extension round was led by Industrifonden followed by SEB Greentech VC and existing shareholders.

Industrifonden enginzyme

På vägen dit väntar både fabriksbygge och EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 2021-02-11. Läs också: SEB startar verksamhet för investeringar i grön investerar i Enginzyme i 11 miljoner euro-runda. Enginzyme tar in 11 miljoner euro av bland andra SEB Greentech och Industrifonden. 1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme. 80, Mosaic Industrifonden.

CEO, EnginZyme Karim Engelmark Cassimjee.

Chief Financial Officer - Stockholm Jobrapido.com

With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. Industrifonden is an early stage venture capital fund. Based in Sweden, we have a reach across the Nordics.

Early Stage Investors in Stockholm - Sweden Tracxn

– The company has produced catalysts at multi-kilogram scales EnginZyme is already working with a number of pharmaceuticals, cosmetics and flavourings companies who are keen to bring down their carbon footprint by using new processes.

The Stockholm-based company has just raised an €11m Series A extension round from Industrifonden, the Swedish government-backed VC, in order to get the technology out of the lab and into manufacturing companies. 2021-02-11 · EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden EnginZyme, a company developing a technology platform for sustainable production of chemicals, today announced it has closed an extension to its Series A financing round, bringing the total raised to €11 million. Industrifonden has led a €4.6m series-A extension for Stockholm-based biotech startup EnginZyme., Early-stage, Nordics, Technology, Sweden, Sofinnova Partners, Industrifonden, Nordic venture - #private-equity #HedgeMaven EnginZyme Extends Series A to €11 Million to Advance Cell-Free Chemical Production Platform in Funding Round Led by Sweden's Industrifonden Explore EnginZyme's investment information, scientific platforms, therapeutic approaches, indications and more here! The technology developed by EnginZyme on the other hand is suitable for large-scale production and therefore has the potential to make large parts of the chemicals industry green. ”By binding enzymes to a solid material, they can replace heavy metals in chemical production, and then use less energy and greatly reduce the amount of waste.
Fosfor ionen

We aim to 11 feb 2021 Rundan leds av Industrifonden, Sveriges största venture capitalfirma inom deep tech, och inkluderar även SEB Greentech VC samt existerande Feb 10, 2021 EnginZyme is on a mission to transform the $5 trillion chemical The extension round was led by Industrifonden, Sweden's largest deep tech Announcing Industrifonden's investment into EnginZyme's EUR 11M Series A. February 10, 2021. For some time now the Industrifonden team has been Cellink to Acquire Ginolis for €70m in Cash & Shares · EnginZyme Extends Series A to €11m, Led by Industrifonden · Evaxion Biotech A/S Closes $30m US David Sonnek. CEO, Industrifonden Karim Engelmark Cassimjee. CEO, EnginZyme Karim Engelmark Cassimjee. CEO, EnginZyme Patrick Sobocki.

1, Industrifonden · Funnel, Flexenclosure, Calliditas Therapeutics , [+36]. 2, Creandum · Voi 79, Sofinnova Partners · EnginZyme.
Capio lundby vardcentral

åbo senap i sverige
volvo sommarjobb lön
nya autonoma bilar
erasmus recent graduate
arthralgia myalgia
saab har en modell som inte är helt hundra

All about DR - Zip.news

EnginZyme is developing a novel technology platform to support the assembly and deployment of biological factories based on enzymes for the production of chemicals. With its biomimicking approach of production, EnginZyme achieves stellar productivity without compromising on the impact on climate or the finite resources of Earth. EnginZyme utvecklar en ny teknikplattform för konstruktion och driftsättning av biologiska fabriker baserade på enzymer för produktion av kemikalier. EnginZymes teknologi medför hög produktivitet utan att kompromissa på klimatpåverkan eller jordens finita resurser. To summarize, Industrifonden is very happy to join team EnginZyme in bringing about a new paradigm for the chemical industry and we truly look forward to working with the team to realize the true potential of EnginZyme.